Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Molecules ; 25(22)2020 Nov 13.
Artigo em Inglês | MEDLINE | ID: mdl-33202703

RESUMO

The carrot plant (Daucus carota) and its components are traditionally reported for the management of gastric ulcers. This study was performed to evaluate the role of carrot when administered concurrently with a conventional antiulcer treatment, pantoprazole, in alleviating gastric and duodenal ulcers in female experimental animals. The study involved standard animal models to determine the ulcer preventive effect using pylorus ligation, ethanol, and stress induced acute gastric ulcer models and duodenal ulcer models involving cysteamine. Acetic acid-induced chronic gastric ulcer and indomethacin-induced gastric ulcer models were used to evaluate the ulcer healing effect. Carrot fruit (500 mg/kg) and its co-administration with pantoprazole produced significant protection in an ethanol- and stress-induced acute gastric ulcer and cysteamine-induced duodenal ulcer. The healing of the acetic acid-induced chronic gastric ulcer was also augmented with this combination. Both total proteins and mucin contents were significantly increased in indomethacin-induced gastric ulcers. Similarly, in pylorus ligation, the pepsin content of gastric juice, total acidity, and free acidity were reduced. Overall, both ulcer preventive effects and ulcer healing properties of the pantoprazole were significantly enhanced in animals who received the co-administration of carrot fruit (500 mg/kg).


Assuntos
Antiulcerosos/administração & dosagem , Daucus carota/química , Indometacina/efeitos adversos , Pantoprazol/administração & dosagem , Preparações de Plantas/administração & dosagem , Piloro/efeitos dos fármacos , Ácido Acético/química , Animais , Antioxidantes/farmacologia , Compostos de Bifenilo/química , Cisteamina/química , Sinergismo Farmacológico , Etanol/química , Feminino , Sequestradores de Radicais Livres/química , Concentração Inibidora 50 , Pepsina A/química , Picratos/química , Ratos , Ratos Wistar
2.
Anal Bioanal Chem ; 412(18): 4343-4352, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32372274

RESUMO

The thiolysis of B-type proanthocyanidins in cocoa by cysteamine was evaluated and optimized for its application in cocoa proanthocyanidin quantification. Four thiolysis products consisting of epicatechin, catechin, and their thioethers formed with cysteamine were separated and characterized by reversed-phase UPLC with photo diode array (PDA) detection and high-resolution mass spectrometry (HRMS). A thiolysis time of 20 min under 60 °C temperature was determined as the optimal condition for cocoa proanthocyanidin depolymerization. The optimized thiolysis condition was applied to four cocoa bean samples for proanthocyanidin quantification, using commercially available procyanidin B2 dimer as a reference standard. Satisfactory linearity and quantification and detection limits were achieved for the calibration curves, and proanthocyanidin contents determined by thiolysis were found to be higher than those determined by a published method based on normal-phase HPLC with fluorescence detection. Results in this study suggest promising application potential of cysteamine as an odorless thiolysis agent in routine quantitative analysis of B-type proanthocyanidins. Graphical abstract.


Assuntos
Cacau/química , Cromatografia de Fase Reversa/métodos , Proantocianidinas/análise , Biflavonoides/análise , Catequina/análise , Cromatografia Líquida de Alta Pressão/métodos , Cisteamina/química , Extratos Vegetais/química
4.
Int J Pharm ; 549(1-2): 466-475, 2018 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-30099213

RESUMO

Cystinosis is a genetic disorder that leads to the formation of cystine crystals in many organs in the body including cornea. Ocular manifestation of this disease is treated by eye drops of cysteamine which can easily oxidize into its disulfide cystamine. The rapid oxidation limits the shelf life as well the duration during which the drug can be used after opening the eye drop bottle. We evaluate two approaches of preventing the oxidation of cysteamine with the goal of increasing the time of use after opening the bottle to one month. The first approach integrates antioxidants such as catalase enzyme and vitamins C and E into the aqueous solution. Results show that catalase is the most effective additive as it decreases the oxidation rate by 58%, which on its own is not sufficient to reach targeted one month stability. The second approach focuses on incorporating diffusion barriers to prevent oxygen from reaching the cysteamine solution. This was accomplished by two methods: formulation of a hydrophobic layer which floats on the surface of the aqueous solution and integration of OMAC® oxygen-resistant material into the eye drop bottle. Both methods delay the onset of cysteamine degradation and decrease the rate of degradation. In particular, an eye drop bottle with three layers of OMAC® has less than 10% degradation after one month of opening the bottle and withdrawing a drop each day. By integrating all three methods, we designed a system where >90% of cysteamine remains in the active form for 70 days after opening the bottle. In addition, we examine the use of OMAC® as heat-sealed pouches for storage of cysteamine eye drop bottles during packaging to eliminate the need for the current approach of freezing the formulation during shipping. The results show that such heat-sealed pouches would keep cysteamine stable for over one year at ambient conditions.


Assuntos
Antioxidantes/química , Catalase/química , Cisteamina/química , Eliminadores de Cistina/química , Embalagem de Medicamentos , Oxigênio/química , Óleo de Soja/química , Administração Oftálmica , Ácido Ascórbico/química , Cisteamina/administração & dosagem , Eliminadores de Cistina/administração & dosagem , Composição de Medicamentos , Estabilidade de Medicamentos , Interações Hidrofóbicas e Hidrofílicas , Soluções Oftálmicas , Oxirredução , Tecnologia Farmacêutica/métodos , Fatores de Tempo , Vitamina E/química
5.
Talanta ; 188: 7-16, 2018 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-30029434

RESUMO

Based on the fluorescent reversible regulation, a novel sensor platform was designed for the detection of DNA intercalators utilizing the intercalation binding of DNA intercalators to DNA as an inherent exhibition and the fluorescence change of quantum dots (QDs) as an external manifestation. To prove its feasibility, acridine orange (AO) was chosen as an example of DNA intercalator. When different concentrations of herring sperm DNA (hsDNA) were added to cysteamine (CA)-capped ZnSe QDs solution, the hsDNA bound with the QDs through electrostatic interaction due to the photoinduced electron transfer from hsDNA to QDs and formed QDs-hsDNA complexes with 1:1 ratio, leading to the fluorescence quenching of the QDs; and upon addition of different concentrations of AO to the QDs-hsDNA complex system, the AO first caused the release of the hsDNA from the complexes and concomitantly bound with them through intercalation binding and formed AO-hsDNA complexes with 1:3 ratio on account of the fact that the intercalation binding constant between AO and hsDNA (1.932 × 105 L/mol) was greater than the electrostatic interaction constant between QDs and hsDNA (7.874 × 104 L/mol), resulting in the fluorescence recovery of the QDs. Therefore, the detection of AO could be achieved through the relationship between the fluorescence recovery yield of the QDs and the concentration of AO added. The results illustrated that the fluorescence recovery yield of the QDs-hsDNA system was linearly dependent to the concentration of AO in the range of 5.0-75.0 × 10-5 mol/L with a detection limit (3σ/K) of 1.5 × 10-5 mol/L. This dual-directional fluorescent regulation provided a novel method for the detection of DNA intercalators such as polycyclic aromatic hydrocarbons and drugs interfering with DNA-synthesis and possessed some potential applications in the investigation of the interactions between DNA intercalators and DNA.


Assuntos
Laranja de Acridina/análise , DNA/química , Elétrons , Substâncias Intercalantes/análise , Pontos Quânticos/química , Espectrometria de Fluorescência/métodos , Animais , Cisteamina/química , DNA/efeitos da radiação , Peixes/genética , Fluorescência , Luz , Limite de Detecção , Masculino , Selênio/química , Espermatozoides/química , Zinco/química
6.
Toxicol Lett ; 289: 75-85, 2018 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-29545173

RESUMO

Among many of the validated methods for testing skin sensitization, direct peptide reactivity assay (DPRA) employs no cells or animals. Although no immune cells are involved in this assay, it reliably predicts the skin sensitization potential of a chemical in chemico. Herein, a new method was developed using endogenous small-molecular-weight compounds, cysteamine and glutathione, rather than synthetic peptides, to differentiate skin sensitizers from non-sensitizers with an accuracy as high as DPRA. The percent depletion of cysteamine and glutathione by test chemicals was measured by an HPLC equipped with a PDA detector. To detect small-size molecules, such as cysteamine and glutathione, a derivatization by 4-(4-dimethylaminophenylazo) benzenesulfonyl chloride (DABS-Cl) was employed prior to the HPLC analysis. Following test method optimization, a cut-off criterion of 7.14% depletion was applied to differentiate skin sensitizers from non-sensitizers in combination of the ratio of 1:25 for cysteamine:test chemical with 1:50 for glutathione:test chemical for the best predictivity among various single or combination conditions. Although overlapping HPLC peaks could not be fully resolved for some test chemicals, high levels of sensitivity (100.0%), specificity (81.8%), and accuracy (93.3%) were obtained for 30 chemicals tested, which were comparable or better than those achieved with DPRA.


Assuntos
Cisteamina/antagonistas & inibidores , Toxidermias/prevenção & controle , Drogas em Investigação/efeitos adversos , Glutationa/antagonistas & inibidores , Modelos Moleculares , Pele/efeitos dos fármacos , Métodos Analíticos de Preparação de Amostras , Cromatografia Líquida de Alta Pressão , Cisteamina/química , Avaliação Pré-Clínica de Medicamentos/métodos , Drogas em Investigação/química , Glutationa/química , Humanos , Indicadores e Reagentes/química , Cinética , Fotometria , Curva ROC , Reprodutibilidade dos Testes , Bibliotecas de Moléculas Pequenas , Espectrofotometria Ultravioleta , p-Dimetilaminoazobenzeno/análogos & derivados , p-Dimetilaminoazobenzeno/química
7.
J Appl Toxicol ; 38(7): 1047-1053, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29572967

RESUMO

Skin sensitization risk assessment of botanical ingredients is necessary for consumers' protection and occupational hazard identification. There are currently very few available alternative methods that can assist in the evaluation of complex mixtures. Chemical methods can provide essential information in a timely manner and thus help to reduce the need for in vivo testing, and they can complement and facilitate targeted in vitro assays. In the present work, the applicability of the high-throughput screening with dansyl cysteamine (DCYA) method for the systematic evaluation of skin sensitization of complex botanicals was explored. Botanical ingredients of four unrelated plant species were obtained and tested with the high-throughput fluorescence method at three concentrations. To illustrate the minimal matrix effects of the tested extracts on the developed method, the least DCYA-reactive extract (Rosa canina) was spiked with known sensitizers at different concentrations. The data obtained from the four plant extracts and the spiking experiments with known sensitizers, suggest that the high-throughput screening-DCYA method can be successfully applied for estimating the skin sensitization potential of complex botanical matrices. This is the first report of an attempt to develop a versatile in chemico method for the rapid detection of reactive skin sensitizers in complex botanical extracts, which could complement the battery of existing validated, non-animal methods.


Assuntos
Alternativas aos Testes com Animais/métodos , Dermatite Alérgica de Contato/etiologia , Ensaios de Triagem em Larga Escala , Extratos Vegetais/toxicidade , Testes de Irritação da Pele/métodos , Alternativas aos Testes com Animais/normas , Calendula , Calibragem , Cinnamomum zeylanicum , Cisteamina/análogos & derivados , Cisteamina/química , Compostos de Dansil/química , Relação Dose-Resposta a Droga , Ensaios de Triagem em Larga Escala/normas , Humanos , Magnolia , Extratos Vegetais/química , Padrões de Referência , Medição de Risco , Rosa , Testes de Irritação da Pele/normas , Espectrometria de Fluorescência
8.
Nucl Med Biol ; 42(3): 317-22, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25537725

RESUMO

INTRODUCTION: A lipiodol solution of (188)Re-4-hexadecyl-2,2,9,9-tetramethyl-4,7-diaza-1,10-decanedithiol (HTDD) has been successfully developed for liver cancer therapy; however, its preparation requires a multi-step synthesis and it is characterized by a low labeling yield. METHODS: We synthesized a new compound, 4-hexadecyl-4,7-diaza-1,10-decanedithioacetate (AHDD), without gem dimethyl groups to address these issues. AHDD was formulated into a kit and was labeled with (188)Re. Biodistribution study was performed using normal BALB/c mice. RESULTS: The kit was labeled with (188)Re with a high efficiency (98.8±0.2%). After extraction with lipiodol, the overall yield of (188)Re-HDD/lipiodol was as high as 90.2±2.6%. A comparative biodistribution study of (188)Re-HTDD and (188)Re-HDD was performed in normal mice after intravenous injection. The lungs were identified as the main uptake site due to capillary-blockage. (188)Re-HDD/lipiodol showed a significantly higher lung uptake than that of (188)Re-HTDD/lipiodol (p<0.05). CONCLUSION: The newly synthesized (188)Re-HDD/lipiodol showed improved radiolabeling yield and biodistribution results compared to (188)Re-HTDD/lipiodol, and may therefore be more suitable for liver cancer therapy.


Assuntos
Complexos de Coordenação/química , Complexos de Coordenação/uso terapêutico , Cisteamina/análogos & derivados , Óleo Etiodado/química , Neoplasias Hepáticas/terapia , Radioisótopos/uso terapêutico , Rênio/uso terapêutico , Animais , Técnicas de Química Sintética , Química Farmacêutica , Complexos de Coordenação/síntese química , Complexos de Coordenação/farmacocinética , Cisteamina/síntese química , Cisteamina/química , Cisteamina/farmacocinética , Cisteamina/uso terapêutico , Composição de Medicamentos , Desenho de Fármacos , Embolização Terapêutica , Camundongos , Camundongos Endogâmicos BALB C , Compostos Organometálicos , Radioquímica , Distribuição Tecidual
9.
Int J Pharm ; 411(1-2): 10-7, 2011 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-21382457

RESUMO

The purpose of this study was to design and characterize a novel cationic thiolated polymer. In this regard a hydroxyethylcellulose-cysteamine conjugate (HEC-cysteamine) was synthesized. Oxidative ring opening with periodate and reductive amination with cysteamine were performed in order to immobilize free thiol groups to HEC. The resulting HEC-cysteamine displayed 2035 ± 162 µmol immobilized free thiol groups and 185 ± 64 µmol disulfide bonds per gram of polymer being soluble in both acidic and basic conditions. Unlike the unmodified HEC, in case of HEC-cysteamine, a three-fold increase in the viscosity was observed when equal volumes of the polymer were mixed with mucin solution. Tablets based on HEC-cysteamine remained attached on freshly excised porcine mucosa for 8 0h and displayed increased disintegration time of 2h. Swelling behavior of HEC-cysteamine tablets in 0.1M phosphate buffer pH 6.8 indicated swelling ratio of 19 within 8h. In contrast, tablets comprising unmodified HEC detached from the mucosa within few seconds and immediately disintegrated. In addition, they did not exhibit swelling behavior. The transport of rhodamine 123 across freshly excised rat intestine enhanced by a value of approximately 1.6-fold (p-value = 0.0024) in the presence of 0.5% (m/v) HEC-cysteamine as compared to buffer control. Result from cytotoxicity test of HEC-cysteamine applied to Caco-2 cells in concentration of 0.5% (m/v) revealed 82.4 ± 4.60% cell viability. According to these results, HEC-cysteamine seems to be a promising polymer for various pharmaceutical applications especially for intestinal drug delivery.


Assuntos
Portadores de Fármacos/síntese química , Sistemas de Liberação de Medicamentos , Desenho de Fármacos , Polímeros/síntese química , Adesivos/análise , Adesivos/síntese química , Aldeídos/síntese química , Aldeídos/química , Cátions/análise , Cátions/síntese química , Celulose/análogos & derivados , Celulose/análise , Celulose/síntese química , Cisteamina/síntese química , Cisteamina/química , Portadores de Fármacos/química , Avaliação Pré-Clínica de Medicamentos , Mucosa Intestinal/metabolismo , Permeabilidade , Polímeros/química , Rodamina 123/metabolismo , Solubilidade , Espectroscopia de Infravermelho com Transformada de Fourier , Compostos de Sulfidrila/síntese química , Compostos de Sulfidrila/química , Comprimidos
10.
J Org Chem ; 75(19): 6696-9, 2010 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-20806911

RESUMO

Cysteamine reduces selenocystamine to form hemiselenocystamine and then cystamine. The rate constants are k(1) = 1.3 × 10(5) M(-1) s(-1); k(-1) = 2.6 × 10(7) M(-1) s(-1); k(2) = 11 M(-1) s(-1); and k(-2) = 1.4 × 10(3) M(-1) s(-1), respectively. Rate constants for reactions of cysteine/selenocystine are similar. Reaction rates of selenium as a nucleophile and as an electrophile are 2-3 and 4 orders of magnitude higher, respectively, than those of sulfur. Sulfides and selenides are comparable as leaving groups.


Assuntos
Cistamina/síntese química , Cisteamina/química , Selênio/química , Enxofre/química , Cistamina/análogos & derivados , Cistamina/química , Estrutura Molecular
11.
Methods Enzymol ; 474: 23-34, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20609902

RESUMO

Dehydroalanine (DHA), alpha,beta-unsaturated amino acid, is found in the position corresponding to the serine, cysteine, and selenocysteine (Sec) residues of various proteins. Proteinaceous Sec is readily oxidized and subsequently undergoes beta-elimination to produce DHA. Glutathione peroxidase (GPx), which contains a Sec at the active site, is irreversibly inactivated by its own substrate as the result of the oxidation of selenium atom followed by the conversion of oxidized Sec to DHA. We developed a convenient method for estimation of the amount of DHA-GPx1 in cell homogenates. This blot-based method depends on specific addition of biotin-conjugated cysteamine to the DHA residue followed by detection of biotinylated protein based on its interaction with streptavidin. The method required an immunoprecipitation of GPx1 before labeling with the cysteamine derivative because many other proteins contain DHA. With the use of this method, we found that conversion of the Sec residue at the active site of GPx1 to DHA occurred during aging of red blood cells (RBCs) in vivo as well as in RBCs exposed to H(2)O(2) generated either externally by glucose oxidase or internally as a result of aniline-induced Hb autoxidation. Accordingly, the content of DHA-GPx1 in each RBC likely reflects total oxidative stress experienced by the cell during its lifetime of 120 days. Previous studies suggested that the activity of GPx1 in RBCs is most influenced by lifestyle and environmental factors such as the use of dietary supplements and smoking habit. Therefore, DHA-GPx1 in RBCs might be a suitable surrogate marker for evaluation of oxidative stress in the body. Our blot-based method for the detection of DHA-GPx1 will be very useful for evaluation of such stress. In addition, similar blot detection method can be devised for other proteins for which immunoprecipitating antibodies are available.


Assuntos
Alanina/análogos & derivados , Biotina/química , Cisteamina/química , Glutationa Peroxidase/análise , Imunoconjugados/química , Imunoprecipitação/métodos , Alanina/análise , Alanina/química , Animais , Células Cultivadas , Glutationa Peroxidase/sangue , Glutationa Peroxidase/química , Humanos , Estreptavidina/química
12.
J Agric Food Chem ; 50(26): 7548-55, 2002 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-12475269

RESUMO

Many byproducts and wastes generated by agroindustries contain polyphenols with potential application as food antioxidants and preventive agents against skin cancer and other diseases. The performance of polyphenolic fractions from Parellada grape (Vitis vinifera) pomace as antioxidants in different physicochemical environments was tested. Fractions containing oligomers with mean degree of polymerization between 3 and 4 and percentage galloylation ca. 30% were the most potent free radical scavengers and efficient antioxidants in an oil-in-water emulsion. A fraction including glycosylated flavonols was also efficient in the emulsion. All the fractions showed low aquatic toxicity and weak influence on proliferation of human melanoma cells.


Assuntos
Antioxidantes/farmacologia , Biflavonoides , Catequina/análise , Flavonoides/análise , Fenóis/análise , Fenóis/farmacologia , Polímeros/análise , Polímeros/farmacologia , Proantocianidinas , Vitis/química , Divisão Celular/efeitos dos fármacos , Fracionamento Químico , Fenômenos Químicos , Físico-Química , Cisteamina/química , Emulsões , Flavonóis , Sequestradores de Radicais Livres/farmacologia , Glicosilação , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Melanoma/patologia , Fenóis/química , Óleos de Plantas/química , Polímeros/química , Células Tumorais Cultivadas
13.
Cancer Lett ; 65(3): 227-32, 1992 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-1516037

RESUMO

N-Nitroso compounds (NOCs) are known to be strong carcinogens in various animals including primates (Preussman and Stewart, (1984) N-Nitroso Compounds). Human exposure to these compounds can be by ingestion or inhalation of preformed NOCs or by endogenous nitrosation from naturally occurring precursors (Bartsch and Montesano, Carcinogenesis, 5 (1984) 1381-1393; Tannebaum (1979) Naturally Occuring Carcinogens, Mutagens and Modulators of Carcinogenesis; Shephard et al., Food Chem. Toxicol., 25 (1987) 91-108). Several factors present in the diet can modify levels of endogenously formed nitrosamines by acting as catalysts or inhibitors. Compounds in the human diet that alter nitrosamine formation would thus play an important role in carcinogenesis study. Earlier researchers have reported the nitrite scavenging nature of sulphydryl compounds (Williams, Chem. Soc. Rev., 15 (1983) 171-196). We therefore studied the modifying effect of sulphydryl compounds viz., cysteine (CE), cystine (CI), glutathione (GU), cysteamine (CEA), cystamine (CEI), cysteic acid (CIA) and thioglycolic acid (TGA) on the nitrosation of model amines viz., pyrrolidine (PYR), piperidine (NPIP) and morpholine (NMOR). Many of these compounds are present in the food we consume. The present work also describes the inhibitory effect of onion and garlic juices on the nitrosation reactions. Both onion and garlic are known to contain sulphur compounds (Block, Sci. Am., 252 (1985) 114-119). Most of these compounds behave as antinitrosating agents and their inhibitory activity towards formation of carcinogenic nitrosamines, under different conditions is described.


Assuntos
Anticarcinógenos/química , Dieta , Nitrosaminas/antagonistas & inibidores , Nitrosação/efeitos dos fármacos , Compostos de Sulfidrila/farmacologia , Allium , Cromatografia Gasosa , Cistamina/química , Cistamina/farmacologia , Cisteamina/química , Cisteamina/farmacologia , Ácido Cisteico/química , Ácido Cisteico/farmacologia , Cisteína/química , Cisteína/farmacologia , Cistina/química , Cistina/farmacologia , Alho , Glutationa/química , Glutationa/farmacologia , Humanos , Morfolinas/antagonistas & inibidores , Morfolinas/metabolismo , Nitrosaminas/metabolismo , Piperidinas/antagonistas & inibidores , Piperidinas/metabolismo , Plantas Medicinais , Pirrolidinas/antagonistas & inibidores , Pirrolidinas/metabolismo , Compostos de Sulfidrila/química , Tioglicolatos/química , Tioglicolatos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA